Abstract: The disclosure relates to fusions of enterotoxigenic Escherichia coli (ETEC) polynucleotides and polypeptides. In one example, a toxiod heat-labile (LT) and heat-stable (STa) fusion is described. This fusion may include LT with a substituted amino acid at position 192, a linker, and STa with a substituted amino acid at positions 11, 12, 13, or 14. Further provided are vaccines containing the disclosed fusions. Example methods for administering to a subject the disclosed vaccines and using the fusions and vaccines to reduce or eliminate contamination of a food or water supply are additionally contemplated.

Abstract: The present invention relates to a process for the preparation of a zeolitic material having a BEA framework structure comprising the steps of: (i) providing one or more zeolitic materials having a BEA framework structure, wherein the BEA framework structure comprises YO2 and X2O3, wherein Y is a tetravalent element, and X is a trivalent element; (ii) subjecting the one or more zeolitic materials provided in step (i) to a procedure for removing at least a portion of X, preferably tetrahedrally coordinated X, from the BEA framework structure; wherein the Y:X molar ratios of the one or more zeolitic materials provided in step (i) are respectively comprised in the range of from 1 to 50.

Abstract: The present invention relates to a process for the alkylation of an organic compound comprising: (a) providing a catalyst comprising one or more zeolitic materials having a BEA framework structure, wherein the BEA framework structure comprises YO2 and optionally comprises X2O3, wherein Y is a tetravalent element, and X is a trivalent element, (b) contacting the catalyst with one or more alkylatable organic compounds in the presence of one or more alkylating agents in one or more reactors for obtaining one or more alkylated organic compounds, wherein the one or more zeolitic materials is obtainable from a synthetic process which does not employ an organotemplate as structure directing agent.

Abstract: A data partitioning method for a distributed parallel database system, comprising creating fact tables and dimension tables according to a constructed distributed parallel database system, inserting records of the dimension tables and the fact tables into nodes according to partitioning rules, replicating the records of dimension tables into the nodes that include fact tables, performing data deletion, and performing data update.

Abstract: There is provided an injection unit.

Abstract: A method (300, 400) of controlling a melt preparation device (102, 110) is provided. The melt preparation device (102, 110) is located upstream from a melt accumulator (122), the melt accumulator (122) and the melt preparation device (102, 110) being part of an injection unit (100) for preparing and injecting molding material and being associated with a target cycle time. The method (300, 400) comprises appreciating (310, 410) an operational parameter associated with the melt accumulator (122); appreciating (320, 420) a target performance indicator associated with operation of the injection unit (100); based on a comparison of the operational parameter to the target performance indicator, generating (330, 430) a control signal for controlling operation of the melt preparation device (102, 110), such that the melt preparation device (102, 110) prepares molding material in an amount sufficient to transfer to the melt accumulator (122) within an allocated portion of the target molding cycle time.

Abstract: The present invention relates to a process for the preparation of a layered silicate containing at least silicon and oxygen, comprising (1) providing a mixture containing silica and/or at least one silica precursor, water, at least one tetraalkylammonium compound selected from the group consisting of diethyldimethylammonium compound, a triethylmethylammonium compound, and a mixture of a diethyldimethylammonium and a triethylmethylammonium compound, and at least one base, and optionally at least one suitable seeding material; and (2) heating of the mixture obtained according to (1) under autogenous pressure (hydrothermal conditions) to a temperature in the range of from to 120 to 160° C. for a period in the range of from 5 to 10 days to give a suspension containing the layered silicate.

Abstract: A process for the preparation of an isomorphously substituted layered silicate comprising (1) providing a mixture containing silica or a precursor thereof, at least one structure directing agent (SDA) allowing for the crystallization of the layered silicate, and water; (2) heating the mixture obtained according to (1) under hydrothermal conditions; (3) adding at least one source at least one element suitable for isomorphous substitution; (4) heating the mixture obtained according to (3) under hydrothermal conditions.

Abstract: The present invention relates to a pillared silicate compound comprising a layered silicate structure, and bridging metal atoms located between adjacent silicate layers of the silicate structure, wherein said bridging metal atoms form at least one covalent bond to each of the adjacent silicate layers, as well as a process for the preparation of a pillared silicate compound, and further includes a pillared silicate compound obtainable and or obtained according to said process, as well as a method of catalyzing a chemical reaction comprising the step of contacting one or more chemical compounds with the any of the aforementioned pillared silicate compounds.

Abstract: The present invention relates to a process for the preparation of a silicate compound, comprising (1) providing at least one layered silicate; and (2) mixing said layered silicate with water and at least one silicon containing compound according to formula R4-mSi[—(SiR2)n—R]m wherein at least one residue R is a leaving group and none of the residues R contains Si; m is 0, 1, 2, 3, or 4; and n is an integer greater than or equal to 0.

Abstract: Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The Escherichia coli strain may produce K88 fimbria and a fusion protein including a mutant LT enterotoxin linked with a STb enterotoxin. An example method for producing a vaccine for porcine post-weaning diarrhea may include providing a first strain of Escherichia coli. The strain may include the eltAB gene and the estB gene. The method may also include amplifying the eltAB gene, mutating the eltAB gene, generating a genetic fusion of the mutant eltAB gene with the estB gene, and transforming a second strain of Escherichia coli with the genetic fusion.

Abstract: The present invention relates to a process for the preparation of an isomorphously substituted RUB-36 silicate comprising (1) providing a mixture containing silica, preferably amorphous silica, and/or at least one silica precursor, water, at least one suitable structure directing agent, (2) heating the mixture obtained according to (1) under hydrothermal conditions to give a suspension containing an RUB-36 silicate, (3) separating the RUB-36 silicate, wherein (a) either the mixture according to (1) contains at least one element suitable for isomorphous substitution and/or (b) the separated RUB-36 silicate according to (3) is subjected to isomorphous substitution.

Abstract: Described is a process for the production of a zeolitic material having an LEV-type framework structure comprising YO2 and optionally comprising X2O3, wherein said process comprises: (1) preparing a mixture comprising one or more sources for YO2, one or more solvents, and optionally comprising seed crystals; and (2) crystallizing the mixture obtained in step (1); wherein Y is a tetravalent element, and X is a trivalent element, wherein the zeolitic material optionally comprises one or more alkali metals M, wherein the molar ratio of the total amount of the one or more solvents to the total amount of the one or more sources for YO2 based on YO2 is 9.5 or less, and wherein for crystallization temperatures of 175° C.

Abstract: Described is a process for the production of a zeolitic material having an LEV-type framework structure comprising YO2 and optionally comprising X2O3, wherein said process comprises (1) preparing a mixture comprising one or more sources for YO2, one or more solvents, and optionally comprising seed crystals; and (2) crystallizing the mixture obtained in step (1); wherein Y is a tetravalent element, and X is a trivalent element, and wherein the mixture crystallized in step (2) contains 3 wt.-% or less of one or more metals M based on 100 wt-% of YO2, preferably 1 wt.-% or less, more preferably 0.5 wt.-% or less, more preferably 0.1 wt.-% or less, more preferably 0.05 wt.-% or less, more preferably 0.01 wt.-% or less, more preferably 0.005 wt.-% or less, more preferably 0.001 wt.-% or less, more preferably 0.0005 wt.-% or less, more preferably 0.0001 wt.-% or less of one or more metals M based on 100 wt.

Abstract: Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The Escherichia coli strain may produce K88 fimbria and a fusion protein including a mutant LT enterotoxin linked with a STb enterotoxin. An example method for producing a vaccine for porcine post-weaning diarrhea may include providing a first strain of Escherichia coli. The strain may include the eltAB gene and the estB gene. The method may also include amplifying the eltAB gene, mutating the eltAB gene, generating a genetic fusion of the mutant eltAB gene with the estB gene, and transforming a second strain of Escherichia coli with the genetic fusion.

Abstract: Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The Escherichia coli strain may produce K88 fimbria and a fusion protein including a mutant LT enterotoxin linked with a STb enterotoxin. An example method for producing a vaccine for porcine post-weaning diarrhea may include providing a first strain of Escherichia coli. The strain may include the eltAB gene and the estB gene. The method may also include amplifying the eltAB gene, mutating the eltAB gene, generating a genetic fusion of the mutant eltAB gene with the estB gene, and transforming a second strain of Escherichia coli with the genetic fusion.

Abstract: Embodiments of the present invention teach a method of controlling a screw in a two-stage injection unit and a system for implementing the method. For example, a method of controlling a screw in a two-stage injection unit, the method executable at a computing apparatus associated with the two-stage injection unit is disclosed. The method comprises receiving an indication of an operational parameter associated with the screw of the two-stage injection unit; based on the indication of the operational parameter, determining a target speed (STARGET) for the screw, the target speed (STARGET) being sufficient to enable the screw to produce a required amount of material in a molten state; causing the screw to rotate at the target speed (STARGET), thereby causing the screw to operate in a substantially continuous manner.

Abstract: Embodiments of the present invention teach a method of controlling a screw in a two-stage injection unit and a system for implementing the method. For example, a method of controlling a screw in a two-stage injection unit, the method executable at a computing apparatus associated with the two-stage injection unit is disclosed. The method comprises receiving an indication of an operational parameter associated with the screw of the two-stage injection unit; based on the indication of the operational parameter, determining a target speed (STARGET) for the screw, the target speed (STARGET) being sufficient to enable the screw to produce a required amount of material in a molten state; causing the screw to rotate at the target speed (STARGET), thereby causing the screw to operate in a substantially continuous manner.

Abstract: A piezoelectric resonator (10) with electrodes (14) having a periodic pattern (28) along a portion of an edge (30) of at least one of the electrodes (26). The periodic pattern (28) has a periodicity that destructively interferes with the undesirable vibrational mode. For example, a rectangular AT-cut quartz resonator, which vibrates in a thickness-shear mode may also possess undesirable flexure and face-shear modes. These modes not only present undesirable spurious frequencies, they also change over temperature, disturbing a frequency-temperature response (16) of the quartz crystal. The periodic pattern (28) substantially reduces these undesirable modes, providing a more uniform frequency-temperature response which is beneficial in temperature compensated crystal oscillator applications.

Abstract: A method of rotating a non-temperature compensated Bechmann curve of a quartz strip. The method includes the steps of determining (102) whether a crystallographic orientation of an AT cut quartz strip is within a desired specification; selecting (104) a predetermined nominal electrode coverage having a nominal electrode width for an in-specification AT cut quartz strip; and tuning (106) an out of specification crystallographic orientation, by: adjusting (108) the electrode width with respect to the nominal electrode width, to bring the out-of-specification crystallographic orientation of an out-of-specification AT cut crystal quartz to within a desired specification having an in-specification Bechmann curve with an inflection point; and rotating (110) an out-of-specification Bechmann curve about the inflection point to substantially approach the desired in-specification Bechmann curve.